Englander Institute for Precision Medicine

Artificial intelligence in oncology: From bench to clinic.

TitleArtificial intelligence in oncology: From bench to clinic.
Publication TypeJournal Article
Year of Publication2022
AuthorsElkhader J, Elemento O
JournalSemin Cancer Biol
Volume84
Pagination113-128
Date Published2022 Sep
ISSN1096-3650
KeywordsArtificial Intelligence, Humans, Medical Oncology, Precision Medicine, Radiology, Reproducibility of Results
Abstract

In the past few years, Artificial Intelligence (AI) techniques have been applied to almost every facet of oncology, from basic research to drug development and clinical care. In the clinical arena where AI has perhaps received the most attention, AI is showing promise in enhancing and automating image-based diagnostic approaches in fields such as radiology and pathology. Robust AI applications, which retain high performance and reproducibility over multiple datasets, extend from predicting indications for drug development to improving clinical decision support using electronic health record data. In this article, we review some of these advances. We also introduce common concepts and fundamentals of AI and its various uses, along with its caveats, to provide an overview of the opportunities and challenges in the field of oncology. Leveraging AI techniques productively to provide better care throughout a patient's medical journey can fuel the predictive promise of precision medicine.

DOI10.1016/j.semcancer.2021.04.013
Alternate JournalSemin Cancer Biol
PubMed ID33915289
Grant ListF31 LM013058 / LM / NLM NIH HHS / United States
R01 CA194547 / CA / NCI NIH HHS / United States
U24 CA210989 / CA / NCI NIH HHS / United States
P50 CA211024 / CA / NCI NIH HHS / United States
UL1 TR002384 / TR / NCATS NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021